Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103750778 | 10375077 | 8 | F | 20140424 | 20160909 | 20140811 | 20160915 | EXP | JP-JNJFOC-20140802616 | JANSSEN | 63.29 | YR | A | F | Y | 59.00000 | KG | 20160915 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103750778 | 10375077 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
| 103750778 | 10375077 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNSPECIFIED | QD | ||||||
| 103750778 | 10375077 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNSPECIFIED | QD | ||||||
| 103750778 | 10375077 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 600 | MG | UNSPECIFIED | QD | ||||||
| 103750778 | 10375077 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNSPECIFIED | QD | ||||||
| 103750778 | 10375077 | 6 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | 1.3 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 7 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | 1 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 8 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .5 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 9 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .6 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 10 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .5 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 11 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .5 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 12 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .6 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 13 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | .5 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 14 | C | PEGINTRON | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | 0 | 1.3 | UG/KG | INJECTION | /wk | |||||||
| 103750778 | 10375077 | 15 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 103750778 | 10375077 | 16 | C | NULOTAN | LOSARTAN POTASSIUM | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 103750778 | 10375077 | 17 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 103750778 | 10375077 | 18 | C | NAUZELIN | DOMPERIDONE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 103750778 | 10375077 | 19 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Oral | 0 | 120 | MG | QD | ||||||||
| 103750778 | 10375077 | 20 | C | CLARITIN | LORATADINE | 1 | Oral | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103750778 | 10375077 | 1 | Chronic hepatitis C |
| 103750778 | 10375077 | 2 | Chronic hepatitis C |
| 103750778 | 10375077 | 3 | Chronic hepatitis C |
| 103750778 | 10375077 | 4 | Chronic hepatitis C |
| 103750778 | 10375077 | 5 | Chronic hepatitis C |
| 103750778 | 10375077 | 6 | Chronic hepatitis C |
| 103750778 | 10375077 | 7 | Chronic hepatitis C |
| 103750778 | 10375077 | 8 | Chronic hepatitis C |
| 103750778 | 10375077 | 9 | Chronic hepatitis C |
| 103750778 | 10375077 | 10 | Chronic hepatitis C |
| 103750778 | 10375077 | 11 | Chronic hepatitis C |
| 103750778 | 10375077 | 12 | Chronic hepatitis C |
| 103750778 | 10375077 | 13 | Chronic hepatitis C |
| 103750778 | 10375077 | 14 | Chronic hepatitis C |
| 103750778 | 10375077 | 15 | Hypertension |
| 103750778 | 10375077 | 16 | Hypertension |
| 103750778 | 10375077 | 17 | Product used for unknown indication |
| 103750778 | 10375077 | 18 | Product used for unknown indication |
| 103750778 | 10375077 | 19 | Prophylaxis |
| 103750778 | 10375077 | 20 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103750778 | 10375077 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103750778 | 10375077 | Anaemia | |
| 103750778 | 10375077 | Hyperuricaemia | |
| 103750778 | 10375077 | Nausea | |
| 103750778 | 10375077 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103750778 | 10375077 | 1 | 20140409 | 20140627 | 0 | |
| 103750778 | 10375077 | 2 | 20140516 | 20140627 | 0 | |
| 103750778 | 10375077 | 3 | 20140424 | 20140501 | 0 | |
| 103750778 | 10375077 | 4 | 20140409 | 20140417 | 0 | |
| 103750778 | 10375077 | 5 | 20140725 | 20140923 | 0 | |
| 103750778 | 10375077 | 6 | 20140409 | 20140417 | 0 | |
| 103750778 | 10375077 | 7 | 20140424 | 20140424 | 0 | |
| 103750778 | 10375077 | 8 | 20140501 | 20140501 | 0 | |
| 103750778 | 10375077 | 9 | 20140509 | 20140613 | 0 | |
| 103750778 | 10375077 | 10 | 20140620 | 20140912 | 0 | |
| 103750778 | 10375077 | 11 | 20140501 | 20140501 | 0 | |
| 103750778 | 10375077 | 12 | 20140509 | 20140613 | 0 | |
| 103750778 | 10375077 | 13 | 20140620 | 20140912 | 0 | |
| 103750778 | 10375077 | 14 | 20140409 | 20140417 | 0 | |
| 103750778 | 10375077 | 15 | 20140409 | 0 | ||
| 103750778 | 10375077 | 16 | 20140409 | 0 | ||
| 103750778 | 10375077 | 17 | 20140424 | 20140509 | 0 | |
| 103750778 | 10375077 | 18 | 20140424 | 20140509 | 0 | |
| 103750778 | 10375077 | 19 | 20140530 | 20140714 | 0 | |
| 103750778 | 10375077 | 20 | 20140718 | 0 |